These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34905957)

  • 1. Prediction of hospital discharge outcome from changes in cerebrospinal fluid/serum albumin quotient and cerebrospinal fluid lactate dehydrogenase in patients with cryptococcal meningitis.
    Huang Y; Zou J; Zhang KM; Li H; Hu DY; Liao WQ; Zhang L; Pan WH
    Future Microbiol; 2022 Mar; 17():223-233. PubMed ID: 34905957
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of hospital discharge outcome from the presenting clinical characteristics and the first cerebrospinal fluid analysis among the patients with cryptococcal meningitis.
    Sathirapanya P; Ekpitakdamrong N; Chusri S; Pruphetkaew N; Chongphattararot P; Nanphan P
    Clin Neurol Neurosurg; 2019 Nov; 186():105539. PubMed ID: 31590063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of follow-up cerebrospinal fluid analysis in cryptococcal meningoencephalitis.
    Skripuletz T; Schwenkenbecher P; Pars K; Stoll M; Conzen J; Bolat S; Pul R; Vonberg RP; Sedlacek L; Wurster U; Stangel M; Trebst C
    Dis Markers; 2014; 2014():162576. PubMed ID: 25374433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
    Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study.
    Qu J; Zhou T; Zhong C; Deng R; Lü X
    BMC Infect Dis; 2017 Jan; 17(1):51. PubMed ID: 28068915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus.
    Liu L; Zhang R; Tang Y; Lu H
    Biosci Trends; 2014 Dec; 8(6):327-32. PubMed ID: 25641179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.
    Hakyemez IN; Erdem H; Beraud G; Lurdes M; Silva-Pinto A; Alexandru C; Bishop B; Mangani F; Argemi X; Poinot M; Hasbun R; Sunbul M; Akcaer M; Alp S; Demirdal T; Angamuthu K; Amer F; Ragab E; Shehata GA; Ozturk-Engin D; Ozgunes N; Larsen L; Zimmerli S; Sipahi OR; Tukenmez Tigen E; Celebi G; Oztoprak N; Yardimci AC; Cag Y
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1231-1240. PubMed ID: 29218468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid microscopy as an index for predicting the prognosis of cryptococcal meningitis patients with and without HIV.
    Zhang K; Li H; Zhang L; Liao W; Ling L; Li X; Lin J; Xu B; Pan W; Zhang Q
    Future Microbiol; 2020 Nov; 15():1645-1652. PubMed ID: 33251866
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
    Lee YC; Wang JT; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.
    Wajanga BM; Kalluvya S; Downs JA; Johnson WD; Fitzgerald DW; Peck RN
    J Int AIDS Soc; 2011 Oct; 14():48. PubMed ID: 21988905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral infarction in HIV-negative patients with cryptococcal meningitis: its predictors and impact on outcomes.
    Tu J; Zhang S; Liu Q; Lin Y
    BMC Infect Dis; 2022 Nov; 22(1):825. PubMed ID: 36352352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.
    Abassi M; Bangdiwala AS; Nuwagira E; Kandole Tadeo K; Okirwoth M; Williams DA; Mpoza E; Tugume L; Ssebambulidde K; Huppler Hullsiek K; Musubire AK; Muzoora C; Rhein J; Meya DB; Boulware DR
    Clin Infect Dis; 2021 Nov; 73(9):e3077-e3082. PubMed ID: 33249459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Features and Prognostic Factors of Cryptococcal Meningitis Caused by Cryptococcus neoformans in Patients With and Without Pulmonary Nodules.
    Cao W; Jian C; Zhang H; Xu S
    Mycopathologia; 2019 Feb; 184(1):73-80. PubMed ID: 29737452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Lactate Levels as a Prognostic Indicator in Patients With Cryptococcal Meningitis Who Are HIV Negative: A Retrospective Cohort Study.
    Tsai YC; Chen YS; Yao CS; Chang RI; Wang NC; Chen JK
    Open Forum Infect Dis; 2024 Oct; 11(10):ofae540. PubMed ID: 39411225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular and lumbar cerebrospinal fluid analysis in 77 HIV-negative patients with Cryptococcal meningitis who received a ventriculoperitoneal shunt.
    Dong Q; Huang Z; Yu P; Song E; Chen Z; Qin F
    Sci Rep; 2022 Dec; 12(1):21366. PubMed ID: 36494487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal meningitis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
    Viriyavejakul P; Tangwanicharoen T; Punpoowong B; Chaisri U; Wilainam P; Nuntakomon D; Yimsamran S; Maneerat Y; Pongponratn E; Wilairatana P; Riganti M
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():33-8. PubMed ID: 15906631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.